148 related articles for article (PubMed ID: 9539780)
21. Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product.
Ishida T; Tsujisaki M; Hinoda Y; Imai K; Yachi A
Jpn J Cancer Res; 1994 Feb; 85(2):172-8. PubMed ID: 7908285
[TBL] [Abstract][Full Text] [Related]
22. Cloning and expression of functional cDNA genes of a mouse/human chimeric antibody rcM4.
Boyd M; Xiang J
Tumori; 1994 Dec; 80(6):473-9. PubMed ID: 7900239
[TBL] [Abstract][Full Text] [Related]
23. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
[TBL] [Abstract][Full Text] [Related]
24. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.
Sato K; Tsuchiya M; Saldanha J; Koishihara Y; Ohsugi Y; Kishimoto T; Bendig MM
Cancer Res; 1993 Feb; 53(4):851-6. PubMed ID: 8428365
[TBL] [Abstract][Full Text] [Related]
25. The construction of a mouse/human chimeric antibody against human breast cancer cells.
Meulemans E; Vandevyver C; Volckaert G; Raus J
Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
[No Abstract] [Full Text] [Related]
26. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
[TBL] [Abstract][Full Text] [Related]
27. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
[TBL] [Abstract][Full Text] [Related]
28. Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition.
Amiri MM; Golsaz-Shirazi F; Soltantoyeh T; Hosseini-Ghatar R; Bahadori T; Khoshnoodi J; Navabi SS; Farid S; Karimi-Jafari MH; Jeddi-Tehrani M; Shokri F
Invest New Drugs; 2018 Apr; 36(2):171-186. PubMed ID: 28983766
[TBL] [Abstract][Full Text] [Related]
29. Production of murine V-human Cr1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR.
Xiang JH; Roder J; Hozumi N
Mol Immunol; 1990 Aug; 27(8):809-17. PubMed ID: 2119481
[TBL] [Abstract][Full Text] [Related]
30. Design of interchain disulfide bonds in the framework region of the Fv fragment of the monoclonal antibody B3.
Jung SH; Pastan I; Lee B
Proteins; 1994 May; 19(1):35-47. PubMed ID: 8066084
[TBL] [Abstract][Full Text] [Related]
31. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
Xiang J; Moyana T; Kalra J; Hamilton T; Qi Y
Mol Biother; 1992 Dec; 4(4):174-83. PubMed ID: 1476671
[TBL] [Abstract][Full Text] [Related]
32. Cloning, expression and characterization of a murine-human chimeric antibody with specificity for pre-S2 surface antigen of hepatitis B virus.
Jin BR; Ryu CJ; Park SS; Namgung U; Hong HJ; Han MH
Mol Immunol; 1993 Dec; 30(18):1647-54. PubMed ID: 8272078
[TBL] [Abstract][Full Text] [Related]
33. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
34. [Vector construction and expression of anti-Aβ human-mouse chimeric antibody against Alzheimer's disease].
Chang D; Zhang JH; Zhao XM; Liang P
Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):542-7. PubMed ID: 21055034
[TBL] [Abstract][Full Text] [Related]
35. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
[TBL] [Abstract][Full Text] [Related]
36. Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity.
Mateo C; Moreno E; Amour K; Lombardero J; Harris W; Pérez R
Immunotechnology; 1997 Mar; 3(1):71-81. PubMed ID: 9154469
[TBL] [Abstract][Full Text] [Related]
37. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
[TBL] [Abstract][Full Text] [Related]
38. Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer.
Bulens F; Vandamme AM; Bernar H; Nelles L; Lijnen RH; Collen D
Eur J Biochem; 1991 Jan; 195(1):235-42. PubMed ID: 1899382
[TBL] [Abstract][Full Text] [Related]
39. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
[TBL] [Abstract][Full Text] [Related]
40. Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen.
Oppezzo P; Osinaga E; Tello D; Bay S; Cantacuzene D; Irigoín F; Ferreira A; Roseto A; Cayota A; Alzari P; Pritsch O
Hybridoma; 2000 Jun; 19(3):229-39. PubMed ID: 10952411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
